KORU Medical Systems (KRMD) Liabilities and Shareholders Equity (2011 - 2026)
KORU Medical Systems (KRMD) posted quarterly Liabilities and Shareholders Equity of $28.6 million for Q1 2026, up 5.05% year-over-year from $27.2 million in Q1 2025, and up 1.39% quarter-over-quarter from $28.2 million in Q4 2025.
KORU Medical Systems (KRMD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has reported Liabilities and Shareholders Equity for 11 consecutive years, with $28.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 5.05% year-over-year to $28.6 million; the TTM figure through Mar 2026 stood at $109.4 million (changed 0.26% YoY), while the FY2025 annual figure was $28.2 million, up 3.61% from the prior year.
- Liabilities and Shareholders Equity advanced to $28.6 million in Q1 2026 per KRMD's latest filing, from $28.2 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $43.4 million in Q1 2022 and bottomed at $25.5 million in Q2 2025.
- Historically, Liabilities and Shareholders Equity has averaged $32.6 million across 5 years, with a median of $28.5 million in 2023.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity sank 32.77% — and 2026, when it climbed 5.05%.
- KORU Medical Systems' Liabilities and Shareholders Equity stood at $42.3 million in 2022, then tumbled by 32.77% to $28.5 million in 2023, then dropped by 4.37% to $27.2 million in 2024, then increased by 3.61% to $28.2 million in 2025, then advanced by 1.39% to $28.6 million in 2026.
- Business Quant data shows KRMD's Liabilities and Shareholders Equity at $28.6 million in Q1 2026, $28.2 million in Q4 2025, and $27.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | KORU Medical Systems | 149.08 Mn | 140.78 Mn | 7.85 Mn | 27.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.96 Mn |
| Mar 31, 2026 | 28.59 Mn |
| Dec 31, 2025 | 28.20 Mn |
| Sep 30, 2025 | 27.10 Mn |
| Jun 30, 2025 | 25.52 Mn |
| Mar 31, 2025 | 27.22 Mn |
| Dec 31, 2024 | 27.22 Mn |
| Sep 30, 2024 | 27.39 Mn |
| Jun 30, 2024 | 27.30 Mn |
| Mar 31, 2024 | 27.50 Mn |
| Dec 31, 2023 | 28.46 Mn |
| Sep 30, 2023 | 35.35 Mn |
| Jun 30, 2023 | 36.00 Mn |
| Mar 31, 2023 | 38.25 Mn |
| Dec 31, 2022 | 42.33 Mn |
| Sep 30, 2022 | 42.67 Mn |
| Jun 30, 2022 | 42.46 Mn |
| Mar 31, 2022 | 43.43 Mn |
| Dec 31, 2021 | 41.29 Mn |
| Sep 30, 2021 | 41.36 Mn |